Clinical Trial Update: Assessment Of The Safety And Efficacy Of BG9924 In Rheumatoid Arthritis (RA) Participants [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing the safety and efficacy of BG9924 in participants with rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• BG9924

Snippet

Sponsor: Biogen | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED